Endotoxin: physical requirements for cell activation

Abstract

Lipopolysaccharide (LPS) is the eminent lipid component of the outer leaflet of the outer membrane of Gram-negative bacteria and the major initiator of innate immune response to bacterial infection. Below the critical micellar concentration (CMC), LPS is exclusively present as a monomer. Above this concentration, aggregates are formed. Increasing the concentration beyond the CMC leads to an increase in aggregate concentration, whereas the concentration of monomers remains constant or even decreases. The question how LPS activates immune cells and whether the aggregate or the monomer is the biologically active unit has been and still is controversial. To prepare clearly defined monomeric solutions, we utilized a dialysis set-up consisting of a donor and an acceptor chamber, separated by a dialysis diaphragm with a cut-off of 5 kDa, thus allowing only monomers to pass. Human mononuclear cells (MNCs) were then stimulated with equal concentrations of aggregates and monomers, respectively, of deep rough mutant LPS from Escherichia coli strain F515 (Re LPS) and TNF-α release was determined. In contrast to earlier and very recent work of others, we started with a preparation of aggregate-suspensions and pure monomer-solutions and show that monomers are significantly less active than aggregates in the absence and presence of serum proteins at identical concentrations. In our model, we propose that LPS aggregates are detected by membrane-associated LBP and intercalated into the cell membrane to bring LPS into close proximity to signaling proteins in the membrane, thus finally leading to cell activation. To support this model, we present data showing that LBP is indeed present in or at the cell membrane of human macrophages.

Keywords

LPS LBP cellular activation aggregate

References

Luderitz O. , Galanos C. , Lehmann V. , Mayer H. , Rietschel ET , Weckesser J. Chemical structure and biological activities of lipid As from various bacterial families . Naturwissenschaften 1978; 65: 578—585 .

Wichmann MW , Inthorn D. , Andress HJ , Schildberg FW Incidence and mortality of severe sepsis in surgical intensive care patients: the influence of patient gender on disease process and outcome . Intensive Care Med 2000; 26: 167—172 .

Venet C. , Zeni F. , Viallon A. et al. Endotoxaemia in patients with severe sepsis or septic shock . Intensive Care Med 2000; 26: 538—544 .

Hardaway RM A review of septic shock . Am Surg 2000; 66: 22-29 .

Wright SD , Ramos RA , Tobias PS , Ulevitch RJ , Mathison JC CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein . Science 1990; 249: 1431—1433 .

Poltorak A. , He X. , Smirnova I. et al. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene . Science 1998; 282: 2085—2088 .

Hoshino K. , Takeuchi O. , Kawai T. et al. Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps gene product . J Immunol 1999; 162: 3749—3752 .

Shimazu R. , Akashi S. , Ogata H. et al. MD-2, a molecule that confers lipopolysaccharide responsiveness on Toll-like receptor 4 . J Exp Med 1999; 189: 1777—1782 .

Schromm AB , Lien E. , Henneke P. et al. Molecular genetic analysis of an endotoxin nonresponder mutant cell line: a point mutation in a conserved region of MD-2 abolishes endotoxin-induced signaling . J Exp Med 2001; 194: 79—88 .

10.

Blunck R. , Scheel O. , Müller M. , Brandenburg K. , Seitzer U. , Seydel U. New insights into endotoxin-induced activation of macrophages: involvement of a K+ channel in transmembrane signaling . J Immunol 2000; 166: 1009—1015 .

11.

Triantafilou M. , Miyake K. , Golenbock DT , Triantafilou K. Mediators of innate immune recognition of bacteria concentrate in lipid rafts and facilitate lipopolysaccharide-induced cell activation . J Cell Sci 2002; 115: 2603—2611 .

12.

Mueller M. , Brandenburg K. , Dedrick R. , Schromm AB , Seydel U. Phospholipids inhibit lipopolysaccharide (LPS)-induced cell activation: a role for LPS-binding protein . J Immunol 2005 ; 174: 1091—1096 .

13.

Schumann RR , Leong SR , Flaggs GW et al. Structure and function of lipopolysaccharide binding protein . Science 1990; 249: 1429—1431 .

14.

Gutsmann T. , Muller M. , Carroll SF , MacKenzie RC , Wiese A. , Seydel U. Dual role of lipopolysaccharide (LPS)-binding protein in neutralization of LPS and enhancement of LPS-induced activation of mononuclear cells . Infect Immun 2001; 69: 6942—6950 .

15.

Brandenburg K. , Mayer H. , Koch Mhj , Weckesser J. , Rietschel ETh, Seydel U. Influence of the supramolecular structure of free lipid A on its biological activity . Eur J Biochem 1993; 218: 555—563 .

16.

Seydel U. , Hawkins L. , Schromm AB et al. The generalized endotoxic principle . Eur J Immunol 2003; 33: 1586—1592 .

17.

Lamping N. , Dettmer R. , Schroeder Nwj et al. LPS-binding protein protects mice from septic shock caused by LPS or Gram-negative bacteria . J Clin Invest 1998; 101: 2065—2071 .

18.

Hailman E. , Lichenstein HS , Wurfel MM et al. Lipopolysaccharide (LPS)-binding protein accelerates the binding of LPS to CD14 . J Exp Med 1994; 179: 269—277 .

19.

Gioannini TL , Teghanemt A. , Zhang D. et al. Isolation of an endotoxin-MD-2 complex that produces Toll-like receptor 4-dependent cell activation at picomolar concentrations . Proc Natl Acad Sci USA 2004 ; 101: 4186—4191 .

20.

Takayama K. , Din ZZ , Mukerjee P. , Cooke PH , Kirkland TN Physicochemical properties of the lipopolysaccharide unit that activates B lymphocytes . J Biol Chem 1990; 265: 14023—14029 .

21.

Takayama K. , Mitchell DH , Din ZZ , Mukerjee P. , Li C. , Coleman DL Monomeric Re lipopolysaccharide from Escherichia coli is more active than the aggregated form in the Limulus amebocyte lysate assay and in inducing Egr-1 mRNA in murine peritoneal macrophages . J Biol Chem 1994; 269: 2241—2244 .

22.

Shnyra A. , Hultenby K. , Lindberg AA Role of the physical state of Salmonella lipopolysaccharide in expression of biological and endotoxic properties . Infect Immun 1993; 61: 5351—5360 .

23.

Schromm AB , Brandenburg K. , Rietschel ETh, Flad H-D, Carroll SF, Seydel U. Lipopolysaccharide binding protein (LBP) mediates CD14-independent intercalation of lipopolysaccharide into phospholipid membranes . FEBS Lett 1996 ; 399: 267—271 .

24.

Mueller M. , Lindner B. , Kusumoto S. , Fukase K. , Schromm AB , Seydel U. Aggregates are the biologically active units of endotoxin . J Biol Chem 2004; 279: 26307—26313 .

25.

Israelachvili JN Intermolecular and Surface Forces, 2 edn. London: Academic Press , 1991.

26.

Grage-Griebenow E. , Lorenzen D. , Fetting R. , Flad HD , Ernst M. Phenotypical and functional characterization of Fc gamma receptor I (CD64)-negative monocytes, a minor human monocyte subpopulation with high accessory and antiviral activity . Eur J Immunol 1993; 23: 3126—3135 .

27.

Muller M. , Scheel O. , Lindner B. , Gutsmann T. , Seydel U. The role of membrane-bound LBP, endotoxin aggregates, and the MaxiK channel in LPS-induced cell activation . J Endotoxin Res 2003; 9: 181—186 .

28.

Dentener MA , Francot Gjm , Buurman WA Bactericidal/ permeability-increasing protein, a lipopolysaccharide-specific protein on the surface of human peripheral blood monocytes . J Infect Dis 1996; 173: 232—235 .

29.

Bazil V. , Horejsi V. , Baudys M. et al. Biochemical characterization of a soluble form of the 53-kDa monocyte surface antigen . Eur J Immunol 1986 ; 16: 1583—1589 .

30.

Dentener MA , Von Asmuth EJU , Francot Gjm , Marra MN , Buurman WA Antagonistic effects of lipopolysaccharide binding protein and bactericidal/permeability-increasing protein on lipopolysaccharide-induced cytokine release by mononuclear phagocytes: competition for binding to lipopolysaccharide . J Immunol 1993; 151: 4258—4265 .

31.

Larrick JW , Hirata M. , Zheng H. et al. A novel granulocyte-derived peptide with lipopolysaccharide-neutralizing activity . J Immunol 1994; 152: 231—240 .

32.

Wurfel MM , Kunitake ST , Lichenstein H. , Kane JP , Wright SD Lipopolysaccharide (LPS)-binding protein is carried on lipoproteins and acts as a cofactor in the neutralization of LPS . J Exp Med 1994; 180: 1025—1035 .